Futura Medical plc
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 13.93 M GBP, the most of which — 13.93 M GBP — came from its top-performing segment, Eroxon, compared to 3.10 M GBP the previous year. The greatest contribution came from United States, which accounted for 7.84 M GBP last year.
By source
By country